These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18591774)

  • 1. Angiotensin II regulates liver regeneration via type 1 receptor following partial hepatectomy in mice.
    Yayama K; Miyagi R; Sugiyama K; Sugaya T; Fukamizu A; Okamoto H
    Biol Pharm Bull; 2008 Jul; 31(7):1356-61. PubMed ID: 18591774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-converting enzyme inhibitor enhances liver regeneration following partial hepatectomy: involvement of bradykinin B2 and angiotensin AT1 receptors.
    Yayama K; Sugiyama K; Miyagi R; Okamoto H
    Biol Pharm Bull; 2007 Mar; 30(3):591-4. PubMed ID: 17329864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined therapy of cilazapril and losartan has no additive effects in ameliorating adriamycin-induced glomerulopathy.
    Kim HJ; Ryu JH; Han SW; Park IK; Paik SS; Park MH; Paik DJ; Chung HS; Kim SW; Lee JU
    Nephron Physiol; 2004; 97(4):p58-65. PubMed ID: 15331931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of adrenotensin on cell proliferation is mediated by angiotensin II in cultured rat mesangial cells.
    Xue H; Yuan P; Zhou L; Yao T; Huang Y; Lu LM
    Acta Pharmacol Sin; 2009 Aug; 30(8):1132-7. PubMed ID: 19597528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic deletion of AT1a receptors attenuates intracellular accumulation of ANG II in the kidney of AT1a receptor-deficient mice.
    Li XC; Navar LG; Shao Y; Zhuo JL
    Am J Physiol Renal Physiol; 2007 Aug; 293(2):F586-93. PubMed ID: 17537986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tgf-beta1 induced by high glucose is controlled by angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker on cultured human peritoneal mesothelial cells.
    Kyuden Y; Ito T; Masaki T; Yorioka N; Kohno N
    Perit Dial Int; 2005; 25(5):483-91. PubMed ID: 16178483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II increases adipose angiotensinogen expression.
    Lu H; Boustany-Kari CM; Daugherty A; Cassis LA
    Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1280-7. PubMed ID: 17213477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of angiotensin II and norepinephrine-induced plasminogen activator inhibitor-1 expression by AT1a receptor deficiency.
    Brown NJ; Bradford J; Wang Z; Lea W; Ma L; Ma J; Vaughan DE; Fogo AB
    Kidney Int; 2007 Jul; 72(1):72-81. PubMed ID: 17429342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are angiotensin II receptor antagonists useful strategies in steatotic and nonsteatotic livers in conditions of partial hepatectomy under ischemia-reperfusion?
    Ramalho FS; Alfany-Fernandez I; Casillas-Ramirez A; Massip-Salcedo M; Serafín A; Rimola A; Arroyo V; Rodés J; Roselló-Catafau J; Peralta C
    J Pharmacol Exp Ther; 2009 Apr; 329(1):130-40. PubMed ID: 19116369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor beta receptor endoglin is expressed in cardiac fibroblasts and modulates profibrogenic actions of angiotensin II.
    Chen K; Mehta JL; Li D; Joseph L; Joseph J
    Circ Res; 2004 Dec; 95(12):1167-73. PubMed ID: 15539634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of AT1a receptor-mediated uptake of angiotensin II by proximal tubule cells: a novel role of the multiligand endocytic receptor megalin.
    Li XC; Zhuo JL
    Am J Physiol Renal Physiol; 2014 Jul; 307(2):F222-33. PubMed ID: 24740791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin type 1a receptor-deficient mice develop diabetes-induced cardiac dysfunction, which is prevented by renin-angiotensin system inhibitors.
    Yong QC; Thomas CM; Seqqat R; Chandel N; Baker KM; Kumar R
    Cardiovasc Diabetol; 2013 Nov; 12():169. PubMed ID: 24215514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telmisartan exerts renoprotective actions via peroxisome proliferator-activated receptor-γ/hepatocyte growth factor pathway independent of angiotensin II type 1 receptor blockade.
    Kusunoki H; Taniyama Y; Azuma J; Iekushi K; Sanada F; Otsu R; Iwabayashi M; Okayama K; Rakugi H; Morishita R
    Hypertension; 2012 Feb; 59(2):308-16. PubMed ID: 22252391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the spleen in liver regeneration in relation to transforming growth factor-β1 and hepatocyte growth factor.
    Lee SC; Jeong HJ; Choi BJ; Kim SJ
    J Surg Res; 2015 Jun; 196(2):270-7. PubMed ID: 25862490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors.
    Ferrario CM; Jessup J; Gallagher PE; Averill DB; Brosnihan KB; Ann Tallant E; Smith RD; Chappell MC
    Kidney Int; 2005 Nov; 68(5):2189-96. PubMed ID: 16221218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AT1 antagonist modulates activin-like kinase 5 and TGF-beta receptor II in the developing kidney.
    Yim HE; Kim MK; Bae IS; Kim JH; Choi BM; Yoo KH; Hong YS; Lee JW
    Pediatr Nephrol; 2006 Oct; 21(10):1377-88. PubMed ID: 16897002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte growth factor attenuates transforming growth factor-β-angiotensin II crosstalk through inhibition of the PTEN/Akt pathway.
    Iekushi K; Taniyama Y; Kusunoki H; Azuma J; Sanada F; Okayama K; Koibuchi N; Iwabayashi M; Rakugi H; Morishita R
    Hypertension; 2011 Aug; 58(2):190-6. PubMed ID: 21670418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibronectin synthesis by high glucose level mediated proliferation of mouse embryonic stem cells: Involvement of ANG II and TGF-beta1.
    Kim YH; Ryu JM; Lee YJ; Han HJ
    J Cell Physiol; 2010 May; 223(2):397-407. PubMed ID: 20112290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guanylyl cyclase-A inhibits angiotensin II type 1A receptor-mediated cardiac remodeling, an endogenous protective mechanism in the heart.
    Li Y; Kishimoto I; Saito Y; Harada M; Kuwahara K; Izumi T; Takahashi N; Kawakami R; Tanimoto K; Nakagawa Y; Nakanishi M; Adachi Y; Garbers DL; Fukamizu A; Nakao K
    Circulation; 2002 Sep; 106(13):1722-8. PubMed ID: 12270869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo regulation of AT1a receptor-mediated intracellular uptake of [125I]Val5-ANG II in the kidneys and adrenals of AT1a receptor-deficient mice.
    Li XC; Zhuo JL
    Am J Physiol Renal Physiol; 2008 Feb; 294(2):F293-302. PubMed ID: 18045833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.